The bill expresses the House of Representatives' sense that mifepristone should be accessible based on its safety and effectiveness.

The bill emphasizes the importance of respecting over 25 years of evidence and hundreds of studies showing mifepristone is safe and effective. It calls for equitable, transparent, and evidence-based policies on medication abortion care. The bill highlights mifepristone's safety record and its approval by the FDA, noting that it has been studied extensively and holds a convincing safety record. It also underscores the importance of preserving access to medication abortion, including through telemedicine and mail-order pharmacies, to ensure equitable access for marginalized communities.

The bill expresses the House of Representatives' sense that mifepristone should be accessible based on its safety and effectiveness.

The bill emphasizes the importance of respecting over 25 years of evidence and hundreds of studies showing mifepristone is safe and effective. It calls for equitable, transparent, and evidence-based policies on medication abortion care. The bill highlights mifepristone's safety record and its approval by the FDA, noting that it has been studied extensively and holds a convincing safety record. It also underscores the importance of preserving access to medication abortion, including through telemedicine and mail-order pharmacies, to ensure equitable access for marginalized communities.